LncRNA PVT1 promotes exosome secretion through YKT6, RAB7, and VAMP3 in pancreatic cancer.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
04 06 2020
Historique:
received: 13 02 2020
accepted: 20 04 2020
pubmed: 6 6 2020
medline: 9 3 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Pancreatic cancer (PC) is one of the deadliest cancers worldwide. Cancer cells secrete excessive numbers of exosomes that play essential roles in tumorigenesis. Long non-coding RNAs (lncRNAs) are essential non-coding RNAs for cancer progression. However, the role of lncRNA plasmacytoma variant translocation 1 (PVT1) in exosome secretion of PC remains to be comprehensively investigated. Thus, nanoparticle tracking analysis and transmission electron microscopy were performed to determine exosome secretion. Confocal microscopy, western blots, real-time PCR, immunofluorescence, pull-down and RNA immunoprecipitation assays, and rescue experiments were applied to investigate the mechanism underlying the role of PVT1 in exosome secretion. The results showed that PVT1 was upregulated in PC cells, along with increased levels of YKT6 v-SNARE homolog (YKT6), ras-related protein Rab-7 (RAB7), and vesicle-associated membrane protein 3 (VAMP3). Also, PVT1 promoted the transportation of multivesicular bodies (MVBs) towards the plasma membrane. In addition, PVT1 promoted the docking of MVBs by altering RAB7 expression and localization. Moreover, PVT1 promoted the fusion of MVBs with the plasma membrane through regulating YKT6 and VAMP3 colocalization and the palmitoylation of YKT6. Taken together, the results suggest that PVT1 promoted exosome secretion of PC cells and thus, can expand the understanding of PVT1 in tumor biology.

Identifiants

pubmed: 32499447
pii: 103268
doi: 10.18632/aging.103268
pmc: PMC7346024
doi:

Substances chimiques

PVT1 long-non-coding RNA, human 0
R-SNARE Proteins 0
RNA, Long Noncoding 0
VAMP3 protein, human 0
Vesicle-Associated Membrane Protein 3 0
YKT6 protein, human 0
rab7 GTP-Binding Proteins 0
rab7 GTP-binding proteins, human 0
rab GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10427-10440

Références

Biochem Biophys Res Commun. 2016 Feb 26;471(1):10-4
pubmed: 26850852
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4815-20
pubmed: 15044687
Mol Cell. 2010 Oct 22;40(2):280-93
pubmed: 20965422
Nat Cell Biol. 2012 Jun 03;14(7):677-85
pubmed: 22660413
PLoS Med. 2010 Apr 20;7(4):e1000267
pubmed: 20422030
BMC Cancer. 2012 Sep 24;12:421
pubmed: 22998595
Nat Cell Biol. 2010 Jan;12(1):19-30; sup pp 1-13
pubmed: 19966785
J Biol Chem. 2009 May 1;284(18):12110-24
pubmed: 19265192
Traffic. 2010 Sep;11(9):1191-204
pubmed: 20545907
Lancet. 2016 Jul 2;388(10039):73-85
pubmed: 26830752
J Transl Med. 2012 Jun 27;10:134
pubmed: 22738135
PLoS Genet. 2017 Apr 12;13(4):e1006698
pubmed: 28403141
Int J Mol Sci. 2013 Jul 09;14(7):14240-69
pubmed: 23839094
Biochim Biophys Acta. 2009 Dec;1793(12):1901-16
pubmed: 19781582
J Leukoc Biol. 2002 Jul;72(1):217-21
pubmed: 12101283
J Cancer Res Clin Oncol. 2018 Nov;144(11):2085-2095
pubmed: 30062486
Mol Pharm. 2019 Jan 7;16(1):24-40
pubmed: 30513203
Clin Chim Acta. 2017 Nov;474:1-7
pubmed: 28866116
Cell Prolif. 2017 Dec;50(6):
pubmed: 29027279
J Biol Chem. 1997 Jul 11;272(28):17776-83
pubmed: 9211930
Cell Adh Migr. 2017 Mar 4;11(2):124-126
pubmed: 27589080
Oncogene. 2007 Jun 21;26(29):4189-98
pubmed: 17237824
Curr Opin Cell Biol. 2014 Aug;29:116-25
pubmed: 24959705
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Nat Commun. 2016 Nov 24;7:13588
pubmed: 27882925
Int J Mol Sci. 2013 Feb 26;14(3):4655-69
pubmed: 23443164
Oncogene. 2017 Oct 12;36(41):5661-5667
pubmed: 28604750
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Technol Cancer Res Treat. 2017 Dec;16(6):819-827
pubmed: 28355965
J Cell Physiol. 2018 May;233(5):4044-4055
pubmed: 28657147
Physiol Rev. 2011 Jan;91(1):119-49
pubmed: 21248164
Biotechnol Adv. 2018 Jan - Feb;36(1):328-334
pubmed: 29248680
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Biomed Res Int. 2014;2014:864894
pubmed: 24963487
Chin J Cancer Res. 2013 Feb;25(1):10-21
pubmed: 23372337
Oncotarget. 2016 May 3;7(18):25408-19
pubmed: 27028998
Biochim Biophys Acta. 2012 Aug;1826(1):103-11
pubmed: 22503823
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
pubmed: 20610543
Biochem J. 2004 Dec 1;384(Pt 2):233-7
pubmed: 15479160
Cell Adh Migr. 2017 Mar 4;11(2):187-195
pubmed: 28129015
Clin Cancer Res. 2012 Aug 15;18(16):4266-76
pubmed: 22896693
Cancer Lett. 2013 Oct 10;339(2):159-66
pubmed: 23791884
Cell. 2009 Feb 20;136(4):629-41
pubmed: 19239885
Clin Dev Immunol. 2011;2011:842849
pubmed: 22190973
Oncotarget. 2016 Aug 9;7(32):51515-51524
pubmed: 27285987
Biochem Soc Trans. 2012 Dec 1;40(6):1337-47
pubmed: 23176478
Biochem Biophys Res Commun. 2011 Apr 1;407(1):1-6
pubmed: 21316338
Biochim Biophys Acta. 2015 Aug;1856(1):151-64
pubmed: 26208723
Oncotarget. 2016 Aug 30;7(35):57379-57390
pubmed: 27429196
Nat Rev Clin Oncol. 2015 Jun;12(6):319-34
pubmed: 25824606
Lancet. 2004 Mar 27;363(9414):1049-57
pubmed: 15051286
Minerva Med. 2015 Jun;106(3):143-9
pubmed: 25668599
Carcinogenesis. 2017 Oct 1;38(10):1036-1046
pubmed: 29048549
Biochim Biophys Acta. 2014 Nov;1839(11):1097-109
pubmed: 25159663
EMBO J. 2004 Jan 14;23(1):45-53
pubmed: 14685280
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Aug;38(4):480-3
pubmed: 27594165
Nat Cell Biol. 2012 Oct;14(10):1036-45
pubmed: 22983114
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087
Cancer Cell. 2016 Apr 11;29(4):452-463
pubmed: 27070700

Auteurs

Chengming Sun (C)

Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, Heilongjiang, China.

Peng Wang (P)

Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, Heilongjiang, China.

Wei Dong (W)

Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, Heilongjiang, China.

Haishi Liu (H)

Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, Heilongjiang, China.

Jianmin Sun (J)

Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, Heilongjiang, China.

Liang Zhao (L)

Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, Heilongjiang, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH